MGTX Company Profile and Key Details

Q: Who are the executives of MGTX?

Mr. Robert J. Wollin J.D.Gen. Counsel & Sec.Dr. Alexandria ForbesChief Executive Officer, Pres & DirectorDr. Stuart Naylor Ph.D.Chief Devel. OfficerMr. Tim RandallSenior Vice President of Risk & Internal ControlsMr. Richard Brian Giroux B.A.Chief Operating Officer & Chief Financial OfficerDr. Alastair Leighton Ph.D.Senior Vice President of Manufacturing & Supply ChainDr. Robert K. Zeldin M.D.Chief Medical OfficerDr. Michel Michaelides M.D.Head of Clinical OphthalmologyDr. Alexandria Forbes Ph.D.Chief Executive Officer, Pres & DirectorMr. Joel P. BrooksSenior Vice President of Fin.

NASDAQ : MGTX

MeiraGTx

$9.40

-0.55-5.53%

At Close 4:00 PM

60.77

BESG ScoreESG Rating

Profile Key Stats Analyst Ratings Ownership Ratios Financials Dividend & splits Sentiment Forecast

Price Chart

Stock Price Today

MeiraGTx Holdings plc (MGTX) stock declined over -5.53%, trading at $9.40 on NASDAQ, down from the previous close of $9.95. The stock opened at $9.88, fluctuating between $9.36 and $9.94 in the recent session.

Stock Snapshot

9.95

Prev. Close

870.04M

Market Cap

9.36

Day Low

-6.62

P/E Ratio

-1.42

EPS (TTM)

-1.97

Cash Flow per Share

9.88

Open

92.56M

Number of Shares

9.94

Day High

77.12%

Free Float in %

2.17

Book Value

768.59K

Volume

Relevant Articles

SEC Fillings

Current Report (8-k)

Filing Date	Accepted Date

Annual Report (10-k)

Filing Date	Accepted Date

Stock Price History Chart

Date	Open	High	Low	Close	Volume
May 15, 2026	9.88	9.94	9.36	9.40	768.59K
May 14, 2026	9.98	10.15	9.50	9.95	904.08K
May 13, 2026	9.76	10.11	9.76	9.97	365.95K
May 12, 2026	9.70	9.95	9.62	9.79	359.41K
May 11, 2026	9.84	10.23	9.80	9.90	462.97K
May 08, 2026	9.72	9.99	9.64	9.82	380.41K
May 07, 2026	9.90	9.98	9.48	9.68	435.68K
May 06, 2026	9.89	10.13	9.64	9.90	494.71K
May 05, 2026	9.86	10.08	9.63	9.75	480.21K
May 04, 2026	9.40	9.82	9.02	9.70	467.77K
Apr 30, 2026	9.01	9.44	8.99	9.22	640.62K
Apr 29, 2026	8.96	9.09	8.75	8.95	764.91K
Apr 28, 2026	9.14	9.35	9.00	9.08	576.72K
Apr 27, 2026	9.14	9.62	8.97	9.13	500.15K
Apr 23, 2026	10.04	10.09	9.19	9.32	1.03M
Apr 22, 2026	10.58	10.59	9.94	10.03	994.27K
Apr 21, 2026	10.55	10.64	9.95	10.17	1.25M
Apr 20, 2026	10.06	10.60	9.92	10.53	1.47M
Apr 17, 2026	9.65	10.33	9.61	10.12	2.29M
Apr 16, 2026	9.55	10.05	8.75	9.48	4.42M

Contact Details

New York City, NY 10016

United States

https://www.meiragtx.com 646 860 7985

About Company

MeiraGTx Holdings plc, a clinical stage gene therapy company, focusing on developing treatments for patients with serious diseases. The company develops various therapies for ocular diseases, including inherited blindness, as well as Xerostomia following radiation treatment for head and neck cancers; degenerative diseases; neurodegenerative diseases, such as amyotrophic lateral sclerosis; and Parkinson's diseases. Its programs in clinical development include Phase 1/2 clinical stage programs in Achromatopsia, X-Linked Retinitis Pigmentosa, RPE65-deficiency, and radiation-induced Xerostomia, as well as Parkinson's program. The company also focuses on initiating a clinical program in xerostomia related to Sjogren's syndrome and have preclinical programs in neurodegenerative diseases. It has a research collaboration agreement with Janssen Pharmaceuticals, Inc. to develop regulatable gene therapy treatment using the company's proprietary riboswitch technology. MeiraGTx Holdings plc was incorporated in 2015 and is based in New York, New York.

Stock Peers

ARGX

-22.81-2.77%

argenx SE$799.32 REGN

-14.62-2.05%

Regeneron Pharmaceuticals, Inc.$698.25 UTHR

-7.21-1.25%

United Therapeutics Corporation$568.58 MDGL

-16.2-3.00%

Madrigal Pharmaceuticals, Inc.$523.69 VRTX

-13.46-2.99%

Vertex Pharmaceuticals Incorporated$436.95 PRAX

-2.94-0.85%

Praxis Precision Medicines, Inc.$342.58 KRTX

0.09+0.03%

Karuna Therapeutics, Inc.$329.83 KRYS

-10.01-3.16%

Krystal Biotech, Inc.$306.29 ALNY

-6.47-2.20%

Alnylam Pharmaceuticals, Inc.$286.98 ASND

-4.99-2.03%

Ascendis Pharma A/S$240.50

Frequently Asked Questions

What is the current MeiraGTx Holdings plc (MGTX) stock price?

MeiraGTx Holdings plc (NASDAQ: MGTX) stock price is $9.40 in the last trading session. During the trading session, MGTX stock reached the peak price of $9.94 while $9.36 was the lowest point it dropped to. The percentage change in MGTX stock occurred in the recent session was -5.53% while the dollar amount for the price change in MGTX stock was - $0.55.

MGTX's industry and sector of operation?

The NASDAQ listed MGTX is part of Biotechnology industry that operates in the broader Healthcare sector. MeiraGTx Holdings plc designs, manufactures, and markets smartphones, personal computers, tablets, wearables, and accessories worldwide.

Who are the executives of MGTX?

Mr. Robert J. Wollin J.D.
Gen. Counsel & Sec.
Dr. Alexandria Forbes
Chief Executive Officer, Pres & Director
Dr. Stuart Naylor Ph.D.
Chief Devel. Officer
Mr. Tim Randall
Senior Vice President of Risk & Internal Controls
Mr. Richard Brian Giroux B.A.
Chief Operating Officer & Chief Financial Officer
Dr. Alastair Leighton Ph.D.
Senior Vice President of Manufacturing & Supply Chain
Dr. Robert K. Zeldin M.D.
Chief Medical Officer
Dr. Michel Michaelides M.D.
Head of Clinical Ophthalmology
Dr. Alexandria Forbes Ph.D.
Chief Executive Officer, Pres & Director
Mr. Joel P. Brooks
Senior Vice President of Fin.

How MGTX did perform over past 52-week?

MGTX's closing price is 95.22% higher than its 52-week low of $4.82 where as its distance from 52-week high of $11.85 is -20.68%.

How many employees does MGTX have?

Number of MGTX employees currently stands at 375.

Link for MGTX official website?

Official Website of MGTX is: https://www.meiragtx.com

How do I contact MGTX?

MGTX could be contacted at phone 646 860 7985 and can also be accessed through its website. MGTX operates from 430 East 29th Street, New York City, NY 10016, United States.

How many shares of MGTX are traded daily?

MGTX stock volume for the day was 768.59K shares. The average number of MGTX shares traded daily for last 3 months was 692.2K.

What is the market cap of MGTX currently?

The market value of MGTX currently stands at $870.04M with its latest stock price at $9.40 and 92.56M of its shares outstanding.

Stocks Telegraph provides information and tools designed to assist investors and Wall Street players. A major goal is to offer financiers comprehensive information that will help them gain insight into investing.

Stocks Telegraph does not provide any advice or recommendations for buying or selling stocks, securities, or other financial products. Information contained on this website is for informational purposes only and should not be construed as professional financial, investment or other advice. Stocks Telegraph is not liable for any loss or damage that may occur as a result of reliance on this data.

Employees	375
Beta	1.4
Sales or Revenue	$14.02M
5Y Sales Change%	0%
Fiscal Year Ends	December
Sector	Healthcare
Industry	Biotechnology

Employees	375
Beta	1.4
Sales or Revenue	$14.02M
5Y Sales Change%	0%
Fiscal Year Ends	December
Sector	Healthcare
Industry	Biotechnology

MGTX Company Profile and Key Details

MeiraGTx

Price Chart

Stock Price Today

Stock Snapshot

Relevant Articles

SEC Fillings

Current Report (8-k)

Annual Report (10-k)

Stock Price History Chart

Contact Details

About Company

Company Information

Stock Peers

Frequently Asked Questions

Price Chart

Stock Price Today

Stock Snapshot

Relevant Articles

SEC Fillings

Current Report (8-k)

Annual Report (10-k)

Stock Price History Chart

Contact Details

About Company

Company Information

Stock Peers

Company Overview

Technical Performance

Valuation Metrics

Dividend & Fair Value

Earnings & Analyst Outlook

Shareholding & Insider Activity

Financial & Profitability Overview

Quarterly Financial Highlights

Price Forecast & Outlook

Key Takeaways

Frequently Asked Questions

Technical Performance

Dividend & Fair Value

Earnings & Analyst Outlook

Shareholding & Insider Activity

Company Overview

Financial & Profitability Overview

Quarterly Financial Highlights

Valuation Metrics

Price Forecast & Outlook

Key Takeaways